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ABSTRACT 
Objective: We conducted a well-designed prevalence study in a rural population of Haryana in Mullana rural area to find out the latest prevalence 
of essential hypertension, the prescription pattern of antihypertensive drugs and the associated risk of new onset of diabetes.  
Methods: A retrospective study was carried out on the patient data (2672 patients) from the years 2009 to 2013 at OPD of M. M. University 
hospital, Mullana to find the previous year’s prevalence of different diseases, including essential hypertension, new onset of diabetes and associated 
risk factors, prescription pattern of antihypertensive drug therapy. Based on the above results, a prospective study was conducted from January 
2015 to December 2016 and total 510 patients (270 essential hypertension and 240 essential hypertension with new onset of diabetes) and 270 
normal individuals were recruited in the study.  
Results: The retrospective study, a total of 2672 patients' data was evaluated which showed 41.21% prevalence of essential hypertension, 11.83% 
new onset of diabetes in Essential hypertension patients and 15.87% diabetic patients. Antihypertensive monotherapy was prescribed to 59.85% 
patients and combination therapy to 40.15% patients while that of a prospective study showed 40.37% patients of monotherapy and 59.63% 
patients of combination therapy. The prospective study also showed that different anthropometric parameters were significantly associated with 
risk of hypertension and new onset of diabetes except for age and height.  
Conclusion: An increase in the prevalence of essential hypertension and associated risk factors was observed when compared with previous 
studies and retrospective study. It is clearly seen by the change in drug therapy pattern and different anthropometric parameters. Implementation 
of a large scale awareness program is needed to combat these metabolic diseases. 
Keywords: Anthropometric Parameters, Antihypertensive Therapy, Essential Hypertension, New Onset of Diabetes, Prevalence Study, Rural Area 




Chronic diseases like hypertension and diabetes mellitus are 
prevailing at an epidemic scale throughout the world due to 
continuous chronic change in the lifestyle pattern of mankind, which 
then further lead to high mortality rates [1, 2]. Even in India, 
hypertension affected 25% of urban and 33% of rural populations. 
The data suggested that among the essential hypertension affected 
population, only 38% of urban and 25% of the rural population are 
being treated for hypertension [3]. By the year 2025, the global load 
of hypertension is expected to increase from 1 billion to 1.56 billion, 
which will further worsen the conditions [4]. Hypertension alone is 
considered as the risk factor for many cardiovascular diseases, 
including new onset of diabetes. Many studies found a close 
association of essential hypertension with diabetes mellitus as both 
share a common metabolic pathway and also both affect the 
pathophysiology of one another [5, 6]. Around one-third 
hypertensive patients are reported to develop diabetes in later 
stages of hypertension [7]. Co-existence of hypertension and 
diabetes at a single time in an individual is 75% more dangerous 
than either a single disease which increases the risk of another 
cardiovascular disease such as coronary heart disease, nephropathy, 
retinopathy and stroke [8, 9]. In addition, certain antihypertensive 
therapies (especially beta-blockers (BBs), diuretics, angiotensin-
converting enzyme inhibitors (ACEIs) and calcium channel blockers 
(CCBs)) on prolonged use (for 3 y or more) are also reported to 
induce type 2 diabetes or glucose dysregulation in hypertensive 
patients under the influence of polymorphic alleles of certain genes 
[10]. Even it is very hard to control hypertension in patients who 
have developed diabetes and a combination of antihypertensive 
therapies is needed to take control over high blood pressure [11]. 
This may further complicate the situation of glycemic dysregulation 
due to excessive use of antihypertensive drugs. Hence, it is better to 
diagnose and treat diabetes in hypertensive patients at an early 
stage to avoid such complications. Therefore, identification of the 
type of hypertensive patients (based on certain clinical markers, 
genetic markers ethnic markers and certain other markers) who are 
more prone to develop diabetes may also help to combat metabolic 
complexities and reduce the mortality associated with these 
diseases. 
Haryana is a northern state of India with people from diverse ethnic 
and cultural groups. An earlier study (in 2011) found a higher 
(38.2%) prevalence of hypertension (59.2% males and 40.8% 
females) in a rural population of Haryana [12]. Therefore, in the 
present study, we tried to find out the current prevalence of 
different diseases, including hypertension, diabetes mellitus and 
new onset of diabetes in hypertensive patients along with the 
different drug therapies in the same rural population of this area. 
MATERIALS AND METHODS 
Ethics 
The study was approved (IEC/670) by the Institutional Ethics 
Committee of M. M. University and a prior written consent was 
obtained from all the participants. 
Study design  
The present study was carried out on the 38,500 inhabitants 
residing in a 30-kilometer radius of Mullana block in the Ambala 
district of Haryana State. A retrospective analysis (on the previous 
year’s patient data) was done to find out the previous five years data 
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on the prevalence of different diseases, including essential 
hypertension and Essential hypertension with new onset of diabetes 
and a prospective study was conducted to assess the risk factors 
associated with essential hypertension and new onset of diabetes in 
these patients. The detailed study design is discussed as given 
below:  
Retrospective study 
The retrospective study was conducted in M. M. Institute of Medical 
Science and Research, Mullana (Haryana) on total 2672 patients 
visiting the OPD of the hospital during the years from 2009 to 2013. 
The retrospective data were collected from the patient data center of 
the university hospital to find out the prevalence of different 
diseases, including essential hypertension and essential 
hypertension with new onset of diabetes in this rural population.  
Prospective study 
The data from our retrospective study suggested that a sufficient 
number of patients are available within the hospital to conduct a 
prospective study on the same area population to assess the risk 
factors associated with essential hypertension and the associated 
new onset of diabetes. The prospective study was conducted on 
patients visiting the medicine OPD of a university hospital from 
January 2015 to December 2016. A sample size of 164 patients 
would be sufficient to represent the essential hypertension 
population residing in the rural area under investigation with a 
power of 80% and a P-value of 0.05. We have selected 510 patients 
(270 essential hypertension patients and 240 essential hypertension 
with new onset of diabetes patients) who visited regularly in 
hospital OPD. Patients who agree to participate were explained the 
nature and the objectives of the study and informed consent were 
obtained individually. In order to make a comparison with normal 
individuals, we have selected normal individuals with age and sex-
matched from the same place and denoted as a normotensive group.  
Data collection 
Various parameters like age, sex, body mass index (BMI), height, 
weight, waist circumference (WC), hip circumference (HC), systolic 
blood pressure (SBP), diastolic blood pressure (DBP), fasting blood 
glucose level (FBG), W/H ratio, education, and family history were 
recorded in a given questionnaire only after taking the patient 
consent. The information about patient’s identity was not included 
with other data and the only physician had the access to this 
information.  
Inclusion criteria 
The below-given selection criteria were followed and essential 
hypertension patients of both sexes between the age group of 18 to 
75 y were included in the study. Patients on treatment with selective 
antihypertensive medication (diuretics, BBs, CCBs) for about 3 y or 
more either as monotherapy and combination therapy (for essential 
hypertension group), essential hypertension patients with new 
onset of diabetes patients (as diagnosed by the physician) (for 
essential hypertension with new onset of diabetes group) and 
normal individuals without any history of essential hypertension 
and diabetes and without any drug therapy were included. 
Exclusion criteria 
The exclusion criteria indicated that all individuals with the age 
below 18 y and above 75 y, essential hypertension patients who 
were on antihypertensive drugs other than diuretics, BBs, and CCB, 
patients with irregular dosing of antihypertensive therapy, patients 
with secondary cause of hypertension, pregnant and lactating 
mothers, non-cooperative and disabled patients were also excluded 
from the study. 
Blood pressure measurements  
The blood pressure recordings were taken by the physicians in OPD. 
An appropriately sized cuff (cuff bladder encircling at least 80 
percent of the arm) was used to ensure accuracy in the palpitatory 
obliteration of radial pulse pressure was obtained before 
ausculating for blood pressure (BP) measurement. Patients were 
made to sit quietly for at least 15 min on a chair and smoking and 
intake of any kind of drugs (which may affect blood pressure) was 
avoided for at least 30 min prior to the BP measurement. Three 
readings were taken at 5 min interval, and the average was 
recorded. By auscultatory method appearance and disappearance of 
Korotkoff sound were taken as indicative of SBP and DBP, 
respectively [13]. 
Blood glucose monitoring  
The FBG level of each recruited patient was monitored to find out 
the essential hypertension patients with new onset of diabetes after 
chronic therapy of diuretics, BBs and CCBs. 
Statistical analysis 
Data analysis was done with the help of an SPSS version 14.5. 
Continuous variables were expressed as means SD. Intergroup 
comparisons were made using student t-test. Allele frequencies 
were calculated from genotype frequencies and were compared 




Total of 2672 patients was included in the study that consists of 
1560 (58.38%) male and 1112 (41.62%) female patients. The 
prevalence rates of different diseases among male and female 
populations are given in below table 1. 
 
Table 1: Gender wise prevalence of different disease in the rural population of Haryana during the y 2009 to 2013 
Disease Male n (%) Female n (%) Total n (%) 
Essential hypertension 577 (21.59) 524 (19.61) 1101 (41.21) 
Diabetes mellitus 242 (9.06) 182 (6.81) 424 (15.87) 
Essential hypertension with new onset of diabetes 122 (4.57) 194 (7.26) 316 (11.83) 
Cardiovascular disease 411 (15.38) 150 (5.61) 561 (21) 
COPD 175 (6.55) 49 (1.83) 224 (8.38) 
Other diseases 33 (1.24) 13 (0.49) 46 (1.72) 
Total 1560 (58.38) 1112 (41.62) 2672 (100) 
n (%)=number of total individuals (value in percentage) 
 
From the above table, a very high prevalence of essential 
hypertension (41.21%) was found followed by CVDs (21%), diabetes 
mellitus (15.87%), essential hypertension with new onset of 
diabetes (11.83%), COPD (8.38%) and other non-serious seasonal 
disease (1.72%) of the total population (fig. 1). 
The male patient population of this rural area showed a high 
prevalence for both essential hypertension (21.59%) and diabetes 
(9.06%) as compared to females (19.61% and 6.81% respectively). 
Essential hypertension with new onset of diabetes was more 
prevalent in females (7.26%) than males (4.57%) among those 
visited the university hospital. CVDs, COPD and other diseases were 
more prevalent in male patients as compared to females.  
This data showed that female patients were more prone to develop 
diabetes and hypertension along with their coexistence (fig. 2). 




Fig. 1: Prevalence of different disease among the patients visited the medicine OPD of a university hospital from 2009 to 2013 
 
 
Fig. 2: Gender wise distribution of different diseases among patients visited the university hospital from 2009 to 2013 
 
Antihypertensive therapy prescription pattern 
Out of total 1101 essential hypertension patients, 59.85% 
patients were prescribed monotherapy and 40.15% were 
prescribed as combination therapy (24.98% on the two-drug 
combination and 15.17% of multiple drug combination therapy) 
as given in table 2. 
Gender wise prescription data revealed that the more number of 
female patients (30.33%) were prescribed with antihypertensive 
monotherapy than male patients (29.52%).  
However, two drug combinations and multiple drug therapies were 
more prescribed in males (14.90% and 7.99%, respectively) than 
females (10.08% and 7.18% respectively) (fig. 3) 
 
Table 2: Prescription pattern of anti-hypertensive therapy among the patients visited the medicine OPD of university hospital from 2009 
to 2013 
Pattern Number of prescriptions Total 
n (%) Male n (%) Female n (%) 
Monotherapy 325 (29.52) 334 (30.33) 659 (59.85) 
Combination therapy 
Two drugs 164 (14.90) 111 (10.08) 275 (24.98) 
Multiple drugs 88 (7.99) 79 (7.18) 167 (15.17) 
Total 577 (52.41) 524 (47.59) 1101 (100.00) 
n (%)=number of total individuals (value in percentage) 
 




Fig. 3: Gender wise prescription pattern of anti-hypertensive drug therapy 
 
The drug wise data showed that among male patients 28.31% were 
prescribed with BBs, 5.54% with ACEI, 27.08% with CCB, 12.92% 
with diuretics and 26.15% with ARB. While among female patients 
33.23% were prescribed with BB, 8.68% with ACEI, 20.06% with 
CCB, 17.66% with diuretics and 20.36% with ARB (fig. 4). Data 
revealed that female patients were most prescribed with BB 
followed by diuretics and ACEI while male patients were mostly 
prescribed with CCB followed by ARB. 
 
 
Fig. 4: Gender wise prescription pattern of monotherapy among essential hypertension patients 
 
Prospective study 
Total of 510 patients was recruited for the study and categorized in 
two groups, i.e. essential hypertension patients (n=270) and 
essential hypertension with new onset of diabetes patients (n=240). 
Individuals without any history of hypertension, diabetes, essential 
hypertension with new onset of diabetes or any other metabolic 
diseases were selected as normal control (n=270).  
Patient information including the history of disease, prescription 
pattern, anthropometric parameters, BP and FBG level 
measurements were taken and discussed in below table 3. 
 
Table 3: Comparative demographic data of normal, essential hypertension and essential hypertension with new onset of diabetes groups 
Parameters Normal Essential  
hypertensive 




M/F 150/120 95/175 80/160 - 
Age (y) 51.82±11.91 53.43±10.86 54.92±9.29 0.0054a,c,ns,b,** 
SBP (mmHg) 123.33±4.99 152.59±10.24 155.4±8.17 0.0001a,b,c,*** 
DBP (mmHg) 81.51±3.73 91.80±2.62 92.31±2.47 0.0001a,b,c,*** 
FBG (mg/dl) 97.18±6.61 107.20±7.85 207.29±81.02 0.0001a,b,c,*** 
Weight (kg) 63.49±8.87 71.96±7.54 75.94±8.64 0.0001a,b,c,*** 
Height (cm) 158.53±9.33 156.89±8.71 158.02±8.36 0.0884a,b,c,ns 
BMI (kg/m2) 25.18±1.86 28.57±2.31 30.35±1.77 0.0001a,b,c,*** 
WC (cm) 76.38±7.52 94.13±7.08 103.13±11.35 0.0001a,b,c,*** 
HC (cm) 90.56±7.14 105.57±10.22 104.92±12.67 0.0001a,b,c,*** 
W/H Ratio 0.85±0.08 0.90±0.06 0.99±0.05 0.0001a,b,c,*** 
Duration of HTN (y) - 4.70±4.11 7.91±4.52 - 
Duration of diabetes (y) - - 5.72±4.32 - 
Statistical analysis of data was carried by one-way ANOVA followed by Tukey’s Multiple Range Test. The values are mean±SD for each group, 
anormal v/s essential hypertension, bnormal v/s essential hypertension with new onset of diabetes, cessential hypertension v/s essential 
hypertension with new onset of diabetes, ***Highly significant, **Moderate significant, nsNon significant 
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The mutual comparison of the demographic details of normal, 
essential hypertension and essential hypertension with new onset of 
diabetes groups revealed that the age was moderately significant for 
normal v/s essential hypertension with new onset of diabetes 
comparison only (p<0.01) and was non-significant for another group 
comparison (p>0.05). Likely, height was also non-significant when 
compared among these three groups (p>0.05). However, all other 
anthropometric and clinical parameters were highly significant 
among the three comparison groups (p<0.0001). 
In socio-demographic data comparison (table 4), in all groups, 
smokers and drinkers were lesser in number than non-smokers and 
non-drinkers. Similarly, vegetarian individuals were higher in 
number as compared to non-vegetarian among disease groups. The 
majority of the patients were belonging to the illiterate and non-
working category having a sedentary lifestyle in both the groups. 
The lower number of patients was having a family history profile. 
Pattern of anti-hypertensive drug therapy among the essential 
hypertension patients  
Out of total 270 essential hypertension patients, monotherapy was 
prescribed to 109 (40.37%) patients while combination drug 
therapy was prescribed to 161 (59.63%) patients (fig. 5). 
 
Table 4: The socio-demographic details of the populations under study 
Parameters Normotensive n (%) Essential hypertension n (%) Essential hypertension with new onset of diabetes n (%) 
Gender 
Male 150 (55.5) 95 (35.1) 80 (33.4) 
Female 120 (44.5) 175 (72.9) 160 (66.6) 
Smoking 
Smoker 108 (40) 60 (22.2) 20 (8.4) 
Non smoker 162 (60) 210 (77.7) 220 (91.6) 
Drinking 
Drinker 60 (22.3) 50 (18.5) 20 (8.4) 
Non drinker 210 (77.7) 220 (81.4) 220 (91.6) 
Food habits 
Vegetarian 126 (46.7) 170 (62.9) 165 (68.7) 
Non-vegetarian 144 (53.3) 100 (37.1) 75 (31.2) 
Occupation 
Own business 72 (26.6) 40 (14.8) 35 (14.5) 
Farming 78 (28.8) 25 (9.2) 40 (16.6) 
Non-workers 36 (13.3) 140 (51.8) 150 (62.5) 
Workers 54 (20) 55 (20.3) 15 (6.25) 
Students 30 (11.11) 0 0 
Education 
Illiterate 96 (35.5) 125 (46.2) 100 (41.6) 
Primary 36 (13.3) 50 (18.5) 55 (22.9) 
Secondary 54 (20) 55 (20.3) 45 (18.7) 
Higher education 84 (31.1) 40 (14.8) 40 (16.6) 
Family History 
Yes 90 (33.3) 55 (20.3) 85 (35.4) 
No 180 (66.6) 215 (79.6) 155 (64.6) 
n(%)=number of total individuals (value in percentage) 
 
 
Fig. 5: Antihypertensive drug therapy prescription pattern among essential hypertension patients 
 
Out of total 109 monotherapy patients, BB and diuretics were 
equally prescribed in 32 (29.36%) patients followed by CCB in 45 
(41.28%) patients (table 5). 
The gender wise data showed that out of total 37 monotherapy 
male patients, BB (29.73%) and a diuretic (29.73%) were most 
prescribed drug therapy followed by CCBs (40.54%). Out of total 
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72 female patients, the almost same trend was observed for BB 
(29.17%), diuretics (29.17%) and CCBs (41.66%) (fig. 6). 
Surprisingly, ACEIs and ARBs were not prescribed to a single 
patient as monotherapy. 
 
Table 5: Prescription pattern of monotherapy among the essential hypertensive patients 
Monotherapy Number of prescriptions Total n (%) 
Male n (%) Female n (%) 
BB 11 (29.73) 21 (29.17) 32 (29.36) 
Diuretics 11 (29.73) 21 (29.17) 32 (29.36) 
CCB 15 (40.54) 30 (41.66) 45 (41.28) 
Total 37 (100.00) 72 (100.00) 109 (100.00) 
n (%)=number of total individuals (value in percentage) 
 
 
Fig. 6: Gender wise distribution of anti-hypertensive drugs as monotherapy 
 
Among total 240 Essential hypertension with new onset of diabetes 
patients, 80 (33.33%) were male and 160 (66.67%) were females. 
Mono drug therapy was prescribed to 78 (32.50%) patients; whereas 
combination therapy was given to 162 (67.50%) patients (fig. 7). 
 
 
Fig. 7: Antihypertensive drug therapy prescription pattern 




Hypertension and diabetes are prevailing throughout the world, 
leading to the risk of other cardiovascular diseases like stroke, heart 
failure, kidney failure and are the major cause of mortality [14]. 
Hypertension and diabetes are interrelated diseases, the 
combination of which becomes lethal to the mankind. Not only 
hypertension is considered as one of the risk factors for developing 
diabetes but also antihypertensive therapy also been found 
associated with new onset of diabetes in essential hypertension 
patients [10]. Therefore, a high prevalence of hypertension is 
dangerous in either way and poses health problems in the mankind.  
In India, the prevalence of hypertension and diabetes is increasing at 
an alarming rate with the development of the country. Availability of 
an exact data of a particular area about the prevalence of 
hypertension, diabetes and other related diseases may help the 
healthcare system to serve in an efficient way and combat the 
diseases effectively. Therefore, in the present study, we tried to 
assess the prevalence of essential hypertension, the prescription 
pattern of antihypertensive drugs, and risk factors for new onset of 
diabetes in hypertensive patients.  
From the retrospective study, we found a very high prevalence of 
essential hypertension (41.21%) and diabetes (15.87%) in the 
overall population (table 1) which is slightly higher than the 
previous study conducted in the same population area by Gupta et 
al., 2011 [12]. The gender wise data revealed that the prevalence of 
hypertension was more in male (21.59%) than females (19.61%). 
Similarly, the prevalence of diabetes was more in males (9.06%) 
than females (6.81%). While the prevalence of essential 
hypertension with new onset of diabetes patients showed that the 
prevalence of new onset of diabetes in hypertensive female patients 
(7.26%) was more than male patients (4.57%). The 
Antihypertensive therapy prescription pattern showed that 
monotherapy was prescribed to about 59.85% patients and a 
combination therapy to 40.15% patients during the year 2009 to 
2013 (table 2). Among which, BBs were the most prescribed drugs 
followed by CCBs and ARBs.  
In prospective study, mutual comparison of different 
anthropometric parameters among normal, essential hypertension 
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and essential hypertension with new onset of diabetes group 
patients (table 3) suggested that the comparative p-value for age and 
height parameters were non-significant (p>0.05) which indicated that 
these two parameters were not the risk factor for essential 
hypertension and new onset of diabetes. But other parameters such as 
SBP, DBP, FBG level, weight, BMI, WC, HC and W/H ratio were differing 
significantly which clearly indicated these parameters as the risk 
factors for essential hypertension which further may be associated 
with new onset of diabetes. From the socio-demographic data, it is 
evident that illiterate people living in sedentary conditions, with 
elevated BP and family history of diabetes were at higher risk of 
hypertension and further diabetes [15, 16].  
A significant shift in the pattern of antihypertensive drug therapy 
from monotherapy to a combination therapy was observed in the 
prospective study (fig. 5) when it was compared with that from the 
retrospective study (table 2). Over these years, more patients were 
shifted to combination drug therapy (59.63%) and a reduction in 
monotherapy patients (40.37%) was observed. The same scenario of 
the antihypertensive therapy prescription pattern was observed for 
essential hypertension with new onset of diabetes patients. This 
indicated the severity of the diseases and their pace with which 
these are spreading. CCBs were most prescribed drugs in the 
prospective study followed by BBs and diuretics, but surprisingly, 
ACEIs and ARBs were not prescribed to even a single patient. 
Therefore, from our data, it was found that the prescription pattern 
of the antihypertensive therapy shifted from monotherapy to 
combination therapy from 2009-2013 data to 2016 data which 
suggest the severity of the disease.  
CONCLUSION 
Our study suggests that essential hypertension is the most prevalent 
disease in the rural population of Haryana in both males and 
females. However, essential hypertension with new onset of 
diabetes was more prevalent in the female population. The severity 
of the disease increased from 2009 to 2016 which resulted in the 
shift of the prescription pattern of the antihypertensive from 
monotherapy to combination therapy in the majority of the patients. 
Different anthropometric parameters are the indicator of risk 
factors associated with essential hypertension and new onset of 
diabetes in these patients. Person’s lifestyle pattern also indicated 
the risk factor for essential hypertension and new onset of diabetes. 
An illiterate person living in sedentary lifestyle is at most risk. 
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